Sole Source Fixed Price Contract for the procurement of “Pharmacy Supplies”-to be Sole Sourced to Program Support Center. , under Request for Quote FDA-RFQ-2021-1238225
Closed Pre-Solicitation Posted
- Solicitation number
- FDA-RFQ-2021-1238225
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 446199 All Other Health and Personal Care Stores
- Place of performance
- Silver Spring MD 20993 USA
Notice details come from SAM.gov. Updated .
Notice text
FDA has a requirement to procure “Pharmacy Supplies”-to be Sole Sourced to the Program Support Center., under Request for Quote FDA-RFQ-2021-1238225. The Division of Applied Regulatory Science (DARS) OCP/OTS/CDER is evaluating in vitro and in vivo pharmacokinetic assessment of biosimilarity and evaluating models of toxicity assessment for new drug classes. As part of this process DARS needs to acquire these pharmacy drugs to evaluate their parameters:
i. Peg-interferon beta - (Plegridy, 125ug syringe, pk of 2 pens); NDC/NSN = 64406-011-01
ii. Interferon beta - (Avonex, 4 - 30ug pre-filled syringes); NDC/NSN = 59627-333-04
iii. Pegloticase (Krystexxa, 8 mg/ml, 1ml vial); NDC/NSN = 75987-080-10
iv. Alirocumab (Praluent, 75 mg/ml, 1ml syringe); NDC/NSN = 0024-5901-01
v. Reslizumab (Cinqair, 10 mg/ml, 10ml vial); NDC/NSN = 59310-610-31.
See attached notice,
Files
| File | Type | Posted |
|---|---|---|
| Notice of Intent to Sole Source.doc | DOC document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity